OTHER
Therapeutics
Review: statins do not protect against development of dementia
| The first 150 words of the full text of this article appear below. |
Are statins effective for prevention of dementia?
Objective diagnosis of dementia, Alzheimers disease or vascular dementia using standardised criteria; or change in Mini-Mental State Examination (MMSE), Alzheimers Disease Assessment Scale-Cognitive or other standardised tests of cognitive performance in patients at risk of Alzheimers disease/vascular dementia.
Systematic review.
MEDLINE, EMBASE, The Specialised Register of the Cochrane Dementia and Cognitive Improvement Group, The Cochrane Library, PsycINFO, CINAHL and LILACS (searched from inception to October 2007), in addition to conference proceedings, theses and ongoing trials.
Two reviewers independently selected and appraised double blind, randomised, placebo controlled trials comparing any statin with placebo (administered for a minimum of 12 months) in people with normal cognitive function but of sufficient age to be at risk of Alzheimers disease (including those at risk of cerebrovascular disease). Exclusions: direct comparison trials or those without a control group.
Two randomised placebo controlled trials were eligible for inclusion:
Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
